NCT02248220View on ClinicalTrials.gov

Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

657

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

October 31, 1999

Conditions
Parkinson Disease
Interventions
DRUG

Pramipexole

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY